GlobeNewsWire · SITC · November 2, 2026

MiNK Therapeutics to Report Third Quarter 2026 Results and Outline Progress in Randomized Clinical Development and Scalable iNKT Cell Therapy

Get the app for more

Explore stock news, insights and company research.